Schonfeld Strategic Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Sell |
2,490
-21,710
| -90% | -$2.27M | ﹤0.01% | 1635 |
|
|
2025
Q1 | $2.82M | Sell |
24,200
-1,180
| -5% | -$138K | 0.02% | 684 |
|
|
2024
Q4 | $2.15M | Sell |
25,380
-56,617
| -69% | -$4.79M | 0.01% | 752 |
|
|
2024
Q3 | $7.37M | Buy |
81,997
+23,088
| +39% | +$2.07M | 0.05% | 322 |
|
|
2024
Q2 | $4.74M | Sell |
58,909
-1,273
| -2% | -$102K | 0.03% | 489 |
|
|
2024
Q1 | $4.8M | Sell |
60,182
-46,660
| -44% | -$3.72M | 0.03% | 557 |
|
|
2023
Q4 | $8.5M | Buy |
106,842
+39,144
| +58% | +$3.12M | 0.06% | 360 |
|
|
2023
Q3 | $4.73M | Sell |
67,698
-7,614
| -10% | -$532K | 0.04% | 483 |
|
|
2023
Q2 | $5.41M | Buy |
75,312
+64,999
| +630% | +$4.67M | 0.05% | 462 |
|
|
2023
Q1 | $636K | Sell |
10,313
-74,042
| -88% | -$4.57M | 0.01% | 1090 |
|
|
2022
Q4 | $6.51M | Buy |
84,355
+34,955
| +71% | +$2.7M | 0.05% | 408 |
|
|
2022
Q3 | $2.2M | Sell |
49,400
-224
| -0.5% | -$9.99K | 0.02% | 820 |
|
|
2022
Q2 | $1.9M | Buy |
49,624
+42,324
| +580% | +$1.62M | 0.02% | 705 |
|
|
2022
Q1 | $302K | Buy |
+7,300
| New | +$302K | ﹤0.01% | 1627 |
|
|
2021
Q4 | – | Sell |
-1,317
| Closed | -$44K | – | 1970 |
|
|
2021
Q3 | $44K | Buy |
+1,317
| New | +$44K | ﹤0.01% | 1919 |
|
|
2020
Q3 | – | Sell |
-19,886
| Closed | -$1.64M | – | 1324 |
|
|
2020
Q2 | $1.64M | Buy |
19,886
+7,267
| +58% | +$598K | 0.04% | 433 |
|
|
2020
Q1 | $742K | Sell |
12,619
-17,569
| -58% | -$1.03M | 0.05% | 464 |
|
|
2019
Q4 | $3.12M | Sell |
30,188
-92,312
| -75% | -$9.54M | 0.08% | 272 |
|
|
2019
Q3 | $2.48M | Sell |
122,500
-487,300
| -80% | -$9.86M | 0.07% | 273 |
|
|
2019
Q2 | $15.7M | Buy |
609,800
+485,300
| +390% | +$12.5M | 0.56% | 39 |
|
|
2019
Q1 | $1.77M | Buy |
+124,500
| New | +$1.77M | 0.06% | 375 |
|